Aeras Global TB Vaccine Foundation Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Aeras Global TB Vaccine Foundation Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3286
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aeras Global TB Vaccine Foundation Inc (Aeras) is a non-profit biotech organization that develops tuberculosis (TB) vaccines. The organization offers TB vaccine candidates, preclinical candidates and vaccine candidates. Its services include portfolio management, preclinical research, clinical trials, research and development, epidemiological studies, and others. Aeras works in partnership with research organizations, public and private sectors, academic organizations, individuals, pharmaceutical and biotechnology companies, funders and policy makers. It conducts a wide range of proof of concept studies in a variety of accepted experimental model systems to support advancement to clinical development. The organization operates in the US, China and South Africa, among others. Aeras is headquartered in Rockville, Maryland, the US.

Aeras Global TB Vaccine Foundation Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
NIBIO and Aeras Enters into Co-Development Agreement with Create Vaccine for TB Vaccines 10
China CDC Enters Into R&D Agreement With Aeras Global For TB Vaccine 11
Aeras Enters Into R&D Agreement With GlaxoSmithKline Vaccines To Develop Tuberculosis Vaccine 12
Aeras Enters Into Co-Development Agreement With Infectious Disease Research Institute For ID93/GLA-SE 13
Aeras Enters Into Co-Development Agreement With Tianjin CanSino For Tuberculosis Vaccine 14
Aeras Enters Into Co-Development Agreement With China National Biotech Group 15
Asset Transactions 16
IDT Biologika Acquires Biopharmaceutical Development Center from Aeras 16
Aeras Global TB Vaccine Foundation Inc – Key Competitors 17
Aeras Global TB Vaccine Foundation Inc – Key Employees 18
Aeras Global TB Vaccine Foundation Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Key Facts 2
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aeras Global TB Vaccine Foundation Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
NIBIO and Aeras Enters into Co-Development Agreement with Create Vaccine for TB Vaccines 10
China CDC Enters Into R&D Agreement With Aeras Global For TB Vaccine 11
Aeras Enters Into R&D Agreement With GlaxoSmithKline Vaccines To Develop Tuberculosis Vaccine 12
Aeras Enters Into Co-Development Agreement With Infectious Disease Research Institute For ID93/GLA-SE 13
Aeras Enters Into Co-Development Agreement With Tianjin CanSino For Tuberculosis Vaccine 14
Aeras Enters Into Co-Development Agreement With China National Biotech Group 15
IDT Biologika Acquires Biopharmaceutical Development Center from Aeras 16
Aeras Global TB Vaccine Foundation Inc, Key Competitors 17
Aeras Global TB Vaccine Foundation Inc, Key Employees 18
Aeras Global TB Vaccine Foundation Inc, Other Locations 19

List of Figures
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Aeras Global TB Vaccine Foundation Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lincoln Pharmaceuticals Ltd (LINCOLN):企業の財務・戦略的SWOT分析
    Lincoln Pharmaceuticals Ltd (LINCOLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • FDM Group (Holdings) plc (FDM):企業の財務・戦略的SWOT分析
    FDM Group (Holdings) plc (FDM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Prakash Constrowell Limited
    Prakash Constrowell Limited - Strategy, SWOT and Corporate Finance Report Summary Prakash Constrowell Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Tuesday Morning Corporation (TUES):企業の財務・戦略的SWOT分析
    Tuesday Morning Corporation (TUES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Tokyo Gas Co., Ltd.:企業の戦略・SWOT・財務分析
    Tokyo Gas Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokyo Gas Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • SciDev Ltd:企業の戦略・SWOT・財務情報
    SciDev Ltd - Strategy, SWOT and Corporate Finance Report Summary SciDev Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Mereo Biopharma Group Plc (MPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a specialty bio-pharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company’s pipeline products include BPS-804, which is used for the treatment of brittle bone sy …
  • Pernod Ricard SA (RI):企業の財務・戦略的SWOT分析
    Pernod Ricard SA (RI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Oglethorpe Power Corporation:企業の戦略・SWOT・財務情報
    Oglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report Summary Oglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sprint Bioscience AB (SPRINT):製薬・医療:M&Aディール及び事業提携情報
    Summary Sprint Bioscience AB (Sprint Bioscience) is a developer of pharmaceutical products in the areas of cancer and metabolism. The company develops STK25, a drug candidate against a new target protein for the treatment of type 2 diabetes; VPS34, a drug candidate for the treatment of various types …
  • Teva Pharmaceutical Industries Ltd (TEVA)-製薬・医療分野:企業M&A・提携分析
    Summary Teva Pharmaceutical Industries Ltd (Teva) carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines in central nervous system (CNS), respiratory, cancer, women’s health and other therapy areas. The company off …
  • Tenaga Nasional Berhad (TENAGA):企業の財務・戦略的SWOT分析
    Tenaga Nasional Berhad (TENAGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Connecticut Municipal Electric Energy Cooperative:企業の戦略的SWOT分析
    Connecticut Municipal Electric Energy Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competi …
  • Belfius Bank Sa
    Belfius Bank Sa - Strategy, SWOT and Corporate Finance Report Summary Belfius Bank Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • TenCate Advanced Armour:企業の戦略・SWOT・財務分析
    TenCate Advanced Armour - Strategy, SWOT and Corporate Finance Report Summary TenCate Advanced Armour - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Symantec Corporation:企業の戦略・SWOT・財務分析
    Symantec Corporation - Strategy, SWOT and Corporate Finance Report Summary Symantec Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Central National Gottesman Inc:企業の戦略・SWOT・財務分析
    Central National Gottesman Inc - Strategy, SWOT and Corporate Finance Report Summary Central National Gottesman Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Banque Internationale à Luxembourg SA:企業の戦略・SWOT・財務情報
    Banque Internationale à Luxembourg SA - Strategy, SWOT and Corporate Finance Report Summary Banque Internationale à Luxembourg SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Selecta Biosciences Inc (SELB):企業の財務・戦略的SWOT分析
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302 and SEL-302. It utilizes synthetic vaccine particle (S …
  • Anergis SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Anergis SA (Anergis) is a clinical stage biopharmaceutical company that discovers, develops and markets immunotherapy products. The company uses synthetic, pharmaceutical-grade contiguous overlapping peptide to derive allergy immunotherapeutics from its proprietary long peptide technology pl …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆